Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects

Mistletoe lectins (ML) have cytotoxic and immunomodulating properties, and subcutaneously applied mistletoe products (MP) containing ML have approval for supportive cancer treatment. MP are also given off-label intravenously, but data about pharmacokinetics are widely lacking. Therefore, the aim of...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Ann-Kathrin Lederer, Sabine Rieger, Michael Schink, Roman Huber
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Subjects:
mistletoe lectins
phase I clinical trial
viscum album
pharmacokinetics
reversible liver injury
Online Access:https://www.mdpi.com/1424-8247/17/3/278

Internet

https://www.mdpi.com/1424-8247/17/3/278

Similar Items